“…Longterm follow-up (> 1 year) and short-term outcome (< 1 year) were reported in 8 [3,7,11,19] and 17 cases [4, 5, 8, 10, 11, 15 -17, 21, 24, 28], respectively. Five cases presented with interval malignancy including cholangiocarcinoma, and small-bowel adenocarcinoma was noted at follow-up [1,4,17]. The longest followup was reported to be 7 years with the patient still alive [4].…”